VolitionRx (VNRX) News Today $0.68 +0.09 (+15.09%) (As of 03:25 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period StockNews.com Begins Coverage on VolitionRx (NYSE:VNRX)StockNews.com assumed coverage on VolitionRx in a research report on Saturday. They issued a "sell" rating for the company.December 14, 2024 | marketbeat.comVolitionRx Appoints LifeSci Advisors as Investor Relations ConsultantsDecember 12, 2024 | prnewswire.comD. Boral Capital Reiterates "Buy" Rating for VolitionRx (NYSE:VNRX)December 12, 2024 | americanbankingnews.comVolitionRx Limited (NYSE:VNRX) Insider Buys $24,903.87 in StockDecember 11, 2024 | insidertrades.comStudy shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screeningDecember 10, 2024 | prnewswire.comZacks Small Cap Increases Earnings Estimates for VolitionRxDecember 10, 2024 | americanbankingnews.comZacks Small Cap Expects Increased Earnings for VolitionRxVolitionRx Limited (NYSE:VNRX - Free Report) - Investment analysts at Zacks Small Cap upped their FY2024 EPS estimates for VolitionRx in a note issued to investors on Wednesday, December 4th. Zacks Small Cap analyst S. Ralston now expects that the company will earn ($0.28) per share for the year,December 9, 2024 | marketbeat.comVolitionRx Announces Pricing of up to $1.9 Million Registered Direct OfferingDecember 6, 2024 | prnewswire.comVolitionRx (NYSE:VNRX) Coverage Initiated by Analysts at StockNews.comStockNews.com assumed coverage on shares of VolitionRx in a research report on Thursday. They issued a "sell" rating for the company.November 28, 2024 | marketbeat.comBenchmark Reaffirms Hold Rating for VolitionRx (NYSE:VNRX)Benchmark reiterated a "hold" rating on shares of VolitionRx in a research note on Friday.November 22, 2024 | marketbeat.comVolitionRx (NYSE:VNRX) Now Covered by Analysts at StockNews.comStockNews.com started coverage on VolitionRx in a research report on Wednesday. They set a "sell" rating on the stock.November 20, 2024 | marketbeat.comVolitionRx reports Q3 revenue up 187% year-over-year to $475KNovember 16, 2024 | markets.businessinsider.comVolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...November 16, 2024 | finance.yahoo.comVolitionRx Limited (VNRX) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comVolitionRx Limited Announces Third Quarter 2024 Financial Results and Business UpdateNovember 14, 2024 | prnewswire.comVolitionRx (NYSE:VNRX) Coverage Initiated at StockNews.comStockNews.com assumed coverage on shares of VolitionRx in a research note on Tuesday. They set a "sell" rating on the stock.November 12, 2024 | marketbeat.comVolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business UpdateNovember 8, 2024 | prnewswire.comVolition Appoints Timothy I. Still as ChairmanNovember 6, 2024 | prnewswire.comVolitionRx (NYSE:VNRX) Now Covered by StockNews.comStockNews.com initiated coverage on VolitionRx in a research report on Monday. They issued a "sell" rating for the company.November 4, 2024 | marketbeat.comMultiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deterioratingOctober 31, 2024 | prnewswire.comVolition to share new 'NETs in sepsis management' data insights at upcoming webinarOctober 9, 2024 | prnewswire.comVolition hosts NETs in sepsis management symposium at ESICM Lives 2024October 3, 2024 | prnewswire.comVolition Appoints Dr. Ethel Rubin as an Independent DirectorSeptember 30, 2024 | prnewswire.comVolitionRx (NYSE:VNRX) Earns Sell Rating from Analysts at StockNews.comStockNews.com initiated coverage on VolitionRx in a research note on Wednesday. They set a "sell" rating for the company.September 25, 2024 | marketbeat.comVolitionRx (NYSE:VNRX) Receives New Coverage from Analysts at StockNews.comStockNews.com assumed coverage on shares of VolitionRx in a research report on Tuesday. They set a "sell" rating on the stock.September 17, 2024 | marketbeat.comVolition Hosts KOL Roundtable on SepsisSeptember 11, 2024 | prnewswire.comInsider Buying: VolitionRx Limited (NYSE:VNRX) Director Buys 150,000 Shares of StockAugust 22, 2024 | insidertrades.comVolitionRx Limited (VNRX) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | seekingalpha.comVolitionRx Limited Announces Second Quarter 2024 Financial Results and Business UpdateAugust 14, 2024 | prnewswire.comVolitionRX Q2 2024 Earnings PreviewAugust 14, 2024 | msn.comVolitionRx Announces Pricing of up to $21.5 Million Registered Direct OfferingAugust 9, 2024 | prnewswire.comVolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business UpdateAugust 6, 2024 | prnewswire.comVolitionRx (NYSE:VNRX) Research Coverage Started at StockNews.comStockNews.com initiated coverage on VolitionRx in a report on Wednesday. They set a "sell" rating on the stock.July 31, 2024 | marketbeat.comVolition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensingJuly 9, 2024 | prnewswire.comStockNews.com Initiates Coverage on VolitionRx (NYSE:VNRX)StockNews.com began coverage on shares of VolitionRx in a research note on Saturday. They issued a "sell" rating for the company.June 29, 2024 | marketbeat.comVolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual MeetingJune 27, 2024 | prnewswire.comVolitionRx Limited (NYSE:VNRX) Forecasted to Earn Q2 2024 Earnings of ($0.09) Per ShareVolitionRx Limited (NYSE:VNRX - Free Report) - Research analysts at Zacks Small Cap lifted their Q2 2024 earnings estimates for shares of VolitionRx in a research report issued to clients and investors on Tuesday, June 25th. Zacks Small Cap analyst S. Ralston now expects that the company will earJune 27, 2024 | marketbeat.comVolitionRx Limited to Present at Jefferies Global Healthcare ConferenceMay 29, 2024 | prnewswire.comCantor Fitzgerald Reiterates Overweight Rating for VolitionRx (NYSE:VNRX)Cantor Fitzgerald reissued an "overweight" rating and issued a $2.50 target price on shares of VolitionRx in a report on Thursday.May 16, 2024 | marketbeat.comVolitionRX Ltd (VNRX) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances and ...May 15, 2024 | finance.yahoo.comVolitionRX: Q1 Earnings SnapshotMay 13, 2024 | washingtonpost.comVolitionRx Limited Announces First Quarter 2024 Financial Results and Business UpdateMay 13, 2024 | prnewswire.comVolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business UpdateMay 8, 2024 | prnewswire.comResearch Analysts Set Expectations for VolitionRx Limited's FY2024 Earnings (NYSE:VNRX)VolitionRx Limited (NYSE:VNRX - Free Report) - Equities researchers at Zacks Small Cap issued their FY2024 earnings per share estimates for shares of VolitionRx in a research report issued to clients and investors on Monday, April 8th. Zacks Small Cap analyst S. Ralston anticipates that the compaApril 10, 2024 | marketbeat.comVolitionRx Limited Forecasted to Post Q1 2024 Earnings of ($0.11) Per Share (NYSE:VNRX)VolitionRx Limited (NYSE:VNRX - Free Report) - Equities research analysts at Zacks Small Cap issued their Q1 2024 earnings estimates for shares of VolitionRx in a research report issued to clients and investors on Monday, April 8th. Zacks Small Cap analyst S. Ralston anticipates that the companyApril 9, 2024 | marketbeat.comVNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method ...April 8, 2024 | msn.comVNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method (Capture -PCR) 2) Nu.Q NET for SepsisApril 8, 2024 | finance.yahoo.comVolitionRx's (VNRX) Overweight Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and set a $2.50 price objective on shares of VolitionRx in a report on Wednesday.March 27, 2024 | marketbeat.comVolitionRx (NYSE:VNRX) Releases Earnings ResultsVolitionRx (NYSE:VNRX - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.11) EPS for the quarter. VolitionRx had a negative net margin of 5,201.69% and a negative return on equity of 7,185.73%.March 26, 2024 | marketbeat.comVNRX Stock Earnings: VolitionRX Meets EPS, Misses Revenue for Q4 2023March 25, 2024 | msn.com Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! VNRX Media Mentions By Week VNRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VNRX News Sentiment▼0.670.55▲Average Medical News Sentiment VNRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VNRX Articles This Week▼31▲VNRX Articles Average Week Get VolitionRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FULC News ACB News FATE News LXEO News DMAC News ZNTL News ATAI News TNYA News ACRS News ACRV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:VNRX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
